As aging populations increase organ demand, regenerative medicine, organoids, and bioprinting technologies aim to transform transplantation into scalable engineered organs.

An exploration of how genetically engineered pig organs are reshaping medicine, ethics, and the boundaries between species as xenotransplantation accelerates biotechnology.

"While lab-grown organoids are routine, scaling them into transplant-ready organs is the ultimate bioengineering challenge. Explore how 2026 breakthroughs in AI-driven vascularization, volumetric bioprinting, and companies like United Therapeutics are solving the 'necrotic core' problem to create a limitless supply of human organs.